[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-healthcare-stocks-with-consistent-10-revenue-growth-ZH":222},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[150,154,158,162,166,170,174,178,182,186,190,194,198,202,206,210,214,218],{"slug":151,"title":152,"modified":153},"bloomberg","Bloomberg","2025-01-16T14:23:44",{"slug":155,"title":156,"modified":157},"morningstar","Morningstar","2025-01-16T14:25:16",{"slug":159,"title":160,"modified":161},"sentieo","Sentieo","2025-01-16T17:58:27",{"slug":163,"title":164,"modified":165},"googlefinance","Google Finance","2025-01-17T19:39:37",{"slug":167,"title":168,"modified":169},"tradingview","TradingView","2025-01-16T18:17:01",{"slug":171,"title":172,"modified":173},"factset","Factset","2025-01-16T18:20:16",{"slug":175,"title":176,"modified":177},"finviz","Finviz","2025-01-16T18:23:40",{"slug":179,"title":180,"modified":181},"ycharts","YCharts","2025-01-16T18:32:19",{"slug":183,"title":184,"modified":185},"marketbeat","MarketBeat","2025-03-11T00:27:23",{"slug":187,"title":188,"modified":189},"benzinga","Benzinga","2025-03-11T00:31:00",{"slug":191,"title":192,"modified":193},"gurufocus","Gurufocus","2025-03-11T00:31:12",{"slug":195,"title":196,"modified":197},"fast-graphs","FAST Graphs","2025-03-11T00:31:19",{"slug":199,"title":200,"modified":201},"tipranks","TipRanks","2025-03-11T00:31:26",{"slug":203,"title":204,"modified":205},"seeking-alpha","Seeking Alpha","2025-03-11T00:31:45",{"slug":207,"title":208,"modified":209},"thestreet","TheStreet","2025-03-11T00:31:52",{"slug":211,"title":212,"modified":213},"investing-com","Investing.com","2025-03-11T00:32:00",{"slug":215,"title":216,"modified":217},"zacks","Zacks","2025-03-26T15:40:40",{"slug":219,"title":220,"modified":221},"alphasense","AlphaSense","2025-03-11T00:32:15",{"post":223,"seo":258,"relatedPosts":264,"suggestedPosts":265},{"id":224,"title":225,"date":226,"modified":227,"excerpt":228,"content":229,"wordCount":230,"lang":231,"uri":232,"slug":233,"cloudinaryAssetId":234,"featuredImageOriginalUrl":235,"featuredImageMetadata":236,"author":238,"editor":244,"categories":249,"relatedPosts":255,"seo":256},77537,"收入持续增长 10%以上的医疗保健类股票","2025-10-01T16:20:00","2025-10-09T13:40:39","\u003Cp>在保险公司的支持和全球需求的推动下，以下 10 只医疗保健类股票的收入增长率始终保持在 10%以上，是注重增长的投资者的首选。\u003C\u002Fp>\n","\n\u003Cp>医疗保健是世界上规模最大、发展最快的行业之一，随着人口老龄化和新疗法的出现，全球支出预计将持续增长。\u003C\u002Fp>\n\n\n\n\u003Cp>在业内，能保持 10%以上收入增长的公司并不多见，它们通常都有几个共同的关键特征。\u003C\u002Fp>\n\n\n\n\u003Cp>它们通常拥有差异化的疗法或技术，受益于强劲的需求顺风，并采用可随着扩张而扩展的业务模式。\u003C\u002Fp>\n\n\n\n\u003Cp>医疗保健行业持续两位数的增长不仅意味着强大的执行力，也使这些公司有能力再投资于创新、拓展新市场并增强竞争优势。对于投资者来说，这些企业可以带来复利回报，同时把握住全球经济中一些最持久的趋势。\u003Cbr>\u003Cbr>以下是持续实现 10% 以上收入增长的 10 只医疗保健股，重点介绍那些最有能力在未来几年继续扩大规模的运营商。\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-table is-style-regular\">\u003Ctable class=\"has-fixed-layout\">\u003Ctbody>\u003Ctr>\u003Ctd>\u003Cstrong>公司名称（股票代码）\u003C\u002Fstrong>\u003C\u002Ftd>\u003Ctd>\u003Cstrong>\u003Cstrong>分析师预测\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Ftd>\u003Ctd>\u003Cstrong>市盈率\u003C\u002Fstrong>\u003C\u002Ftd>\u003C\u002Ftr>\u003Ctr>\u003Ctd>礼来公司（LLY）\u003C\u002Ftd>\u003Ctd>21.3%\u003C\u002Ftd>\u003Ctd>26.42\u003C\u002Ftd>\u003C\u002Ftr>\u003Ctr>\u003Ctd>诺和诺德公司 (NVO)\u003C\u002Ftd>\u003Ctd>12.9%\u003C\u002Ftd>\u003Ctd>14.09\u003C\u002Ftd>\u003C\u002Ftr>\u003Ctr>\u003Ctd>DexCom (DXCM)\u003C\u002Ftd>\u003Ctd>35.5%\u003C\u002Ftd>\u003Ctd>31.95\u003C\u002Ftd>\u003C\u002Ftr>\u003Ctr>\u003Ctd>Insulet 公司 (PODD)\u003C\u002Ftd>\u003Ctd>4.0%\u003C\u002Ftd>\u003Ctd>67.96\u003C\u002Ftd>\u003C\u002Ftr>\u003Ctr>\u003Ctd>直觉外科 (ISRG)\u003C\u002Ftd>\u003Ctd>23.0%\u003C\u002Ftd>\u003Ctd>55.26\u003C\u002Ftd>\u003C\u002Ftr>\u003Ctr>\u003Ctd>Inspire Medical Systems (INSP)\u003C\u002Ftd>\u003Ctd>53.9%\u003C\u002Ftd>\u003Ctd>103.44\u003C\u002Ftd>\u003C\u002Ftr>\u003Ctr>\u003Ctd>埃佳特科学公司（EXAS）\u003C\u002Ftd>\u003Ctd>32.8%\u003C\u002Ftd>\u003Ctd>66.41\u003C\u002Ftd>\u003C\u002Ftr>\u003Ctr>\u003Ctd>Moderna (MRNA)\u003C\u002Ftd>\u003Ctd>88.7%\u003C\u002Ftd>\u003Ctd>-2.39\u003C\u002Ftd>\u003C\u002Ftr>\u003Ctr>\u003Ctd>Align Technology (ALGN)\u003C\u002Ftd>\u003Ctd>31.3%\u003C\u002Ftd>\u003Ctd>13.45\u003C\u002Ftd>\u003C\u002Ftr>\u003Ctr>\u003Ctd>Guardant Health (GH) \u003C\u002Ftd>\u003Ctd>-9%\u003C\u002Ftd>\u003Ctd>-36.95\u003C\u002Ftd>\u003C\u002Ftr>\u003C\u002Ftbody>\u003C\u002Ftable>\u003C\u002Ffigure>\n\n\n\n\u003Cp>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cem>\u003Cstrong>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003Cem>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog-compoundersreport\">解锁我们的免费报告：根据华尔街的增长预期，5家价值被低估的复合型企业具有上升空间，可带来跑赢市场的回报（注册 TIKR，免费） >>>\u003C\u002Fa>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Cp>以下是目前价值可能被低估得最厉害的 3 种股票：\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-礼来公司-lly\">礼来公司\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=285467&tid=2626794&ref=tikrblog\">（LLY）\u003C\u002Fa>\u003C\u002Fh2>\n\n\n\u003Cdiv class=\"wp-block-image\">\n\u003Cfigure class=\"aligncenter size-full\">\u003Cimg width=\"1939\" height=\"2560\" data-public-id=\"images\u002FLLY_valuation_model-2\u002FLLY_valuation_model-2.png\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1939,h_2560,c_scale\u002Ff_webp,q_auto\u002Fv1756563352\u002Fimages\u002FLLY_valuation_model-2\u002FLLY_valuation_model-2.png?_i=AA\" alt=\"\" class=\"wp-post-77537 wp-image-59517 wp-image-59518\" style=\"object-fit:cover\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1756563352\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1939,h_2560,c_scale\u002Ff_webp,q_auto\u002Fv1756563352\u002Fimages\u002FLLY_valuation_model-2\u002FLLY_valuation_model-2.png?_i=AA 1939w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_227,h_300,c_scale\u002Ff_webp,q_auto\u002Fv1756563352\u002Fimages\u002FLLY_valuation_model-2\u002FLLY_valuation_model-2.png?_i=AA 227w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_775,h_1024,c_scale\u002Ff_webp,q_auto\u002Fv1756563352\u002Fimages\u002FLLY_valuation_model-2\u002FLLY_valuation_model-2.png?_i=AA 775w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_1014,c_scale\u002Ff_webp,q_auto\u002Fv1756563352\u002Fimages\u002FLLY_valuation_model-2\u002FLLY_valuation_model-2.png?_i=AA 768w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1163,h_1536,c_scale\u002Ff_webp,q_auto\u002Fv1756563352\u002Fimages\u002FLLY_valuation_model-2\u002FLLY_valuation_model-2.png?_i=AA 1163w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1551,h_2048,c_scale\u002Ff_webp,q_auto\u002Fv1756563352\u002Fimages\u002FLLY_valuation_model-2\u002FLLY_valuation_model-2.png?_i=AA 1551w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_1585,c_scale\u002Ff_webp,q_auto\u002Fv1756563352\u002Fimages\u002FLLY_valuation_model-2\u002FLLY_valuation_model-2.png?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_1849,c_scale\u002Ff_webp,q_auto\u002Fv1756563352\u002Fimages\u002FLLY_valuation_model-2\u002FLLY_valuation_model-2.png?_i=AA 1400w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_396,c_scale\u002Ff_webp,q_auto\u002Fv1756563352\u002Fimages\u002FLLY_valuation_model-2\u002FLLY_valuation_model-2.png?_i=AA 300w\" sizes=\"auto, (max-width: 1939px) 100vw, 1939px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">礼来指导估值模型\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">(TIKR\u003C\u002Fa>\u003C\u002Fstrong>)\u003C\u002Ffigcaption>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\u003Cp>礼来已成为医疗保健行业最可靠的增长引擎之一，近年来的年复合收入增长率远高于 20%。其主要驱动力是通过 Mounjaro 和 Zepbound 等大片药物在 GLP-1 领域占据领先地位，这些药物正在改变糖尿病和肥胖症的治疗格局。这些疗法在全球范围内得到了爆炸性的应用，肥胖症治疗成为几十年来最大的制药机会之一。礼来公司还投入巨资扩大生产能力，以满足激增的需求，确保其收入保持稳定增长。\u003C\u002Fp>\n\n\n\n\u003Cp>除了 GLP-1 产品组合，礼来的增长还得益于其他治疗领域的多样化，包括神经科学、免疫学和肿瘤学。治疗阿尔茨海默病的 Donanemab 尚未获得监管部门的批准，它的上市将为这一服务不足的领域带来数十亿美元的收入。\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cem>\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">使用 TIKR（免费）查找我们今天\u003Cstrong>比礼来\u003C\u002Fstrong>更看好的股票 >>>\u003C\u002Fa>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-dexcom-dxcm\">\u003Cstrong>DexCom \u003C\u002Fstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=114039&tid=22036506&ref=tikrblog\">(DXCM\u003C\u002Fa>)\u003C\u002Fh2>\n\n\n\u003Cdiv class=\"wp-block-image\">\n\u003Cfigure class=\"aligncenter size-full\">\u003Cimg width=\"1939\" height=\"2560\" data-public-id=\"images\u002FDXCM_valuation_model\u002FDXCM_valuation_model.png\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1939,h_2560,c_scale\u002Ff_webp,q_auto\u002Fv1756563565\u002Fimages\u002FDXCM_valuation_model\u002FDXCM_valuation_model.png?_i=AA\" alt=\"\" class=\"wp-post-77537 wp-image-59526 wp-image-59527\" style=\"object-fit:cover\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1756563565\" data-seo=\"1\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">DexCom 指导估值模型\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">(TIKR\u003C\u002Fa>\u003C\u002Fstrong>)\u003C\u002Ffigcaption>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\u003Cp>Dexcom 持续实现两位数的营业额增长，巩固了其在糖尿病管理技术领域的领先地位。公司的旗舰产品连续血糖监测（CGM）设备减少了对指血测试的需求，实现了实时、数据驱动的疾病管理，从而改变了患者护理方式。随着支付方扩大覆盖范围，采用范围从 1 型糖尿病患者扩大到 2 型糖尿病患者，Dexcom 正在开拓一个更大的可解决市场，并保持 15-20% 的年收入增长。\u003C\u002Fp>\n\n\n\n\u003Cp>重要的是，Dexcom 的增长不仅在于扩大用户群，还在于提高患者保留率和设备创新。Dexcom G7 的推出受到了市场的强烈追捧，它提供了更高的准确性和便利性。国际扩张也在加速，欧洲和新兴市场对收入的贡献更大。随着全球糖尿病患者人数的增加和对数字健康的重视，Dexcom 将在未来保持两位数的收入增长。\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cem>\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">价值型股票，如 Dexcom 和 TIKR >>> 速度更快\u003C\u002Fa>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-insulet-公司-podd\">\u003Cstrong>Insulet 公司 \u003C\u002Fstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=618908&tid=34384837&ref=tikrblog\">(PODD\u003C\u002Fa>)\u003C\u002Fh2>\n\n\n\u003Cdiv class=\"wp-block-image\">\n\u003Cfigure class=\"aligncenter size-full\">\u003Cimg width=\"1939\" height=\"2560\" data-public-id=\"images\u002FPODD_valuation_model\u002FPODD_valuation_model.png\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1939,h_2560,c_scale\u002Ff_webp,q_auto\u002Fv1756563746\u002Fimages\u002FPODD_valuation_model\u002FPODD_valuation_model.png?_i=AA\" alt=\"\" class=\"wp-post-77537 wp-image-59535 wp-image-59536\" style=\"object-fit:cover\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1756563746\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1939,h_2560,c_scale\u002Ff_webp,q_auto\u002Fv1756563746\u002Fimages\u002FPODD_valuation_model\u002FPODD_valuation_model.png?_i=AA 1939w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_227,h_300,c_scale\u002Ff_webp,q_auto\u002Fv1756563746\u002Fimages\u002FPODD_valuation_model\u002FPODD_valuation_model.png?_i=AA 227w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_775,h_1024,c_scale\u002Ff_webp,q_auto\u002Fv1756563746\u002Fimages\u002FPODD_valuation_model\u002FPODD_valuation_model.png?_i=AA 775w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_1014,c_scale\u002Ff_webp,q_auto\u002Fv1756563746\u002Fimages\u002FPODD_valuation_model\u002FPODD_valuation_model.png?_i=AA 768w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1163,h_1536,c_scale\u002Ff_webp,q_auto\u002Fv1756563746\u002Fimages\u002FPODD_valuation_model\u002FPODD_valuation_model.png?_i=AA 1163w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1551,h_2048,c_scale\u002Ff_webp,q_auto\u002Fv1756563746\u002Fimages\u002FPODD_valuation_model\u002FPODD_valuation_model.png?_i=AA 1551w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_1585,c_scale\u002Ff_webp,q_auto\u002Fv1756563746\u002Fimages\u002FPODD_valuation_model\u002FPODD_valuation_model.png?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_1849,c_scale\u002Ff_webp,q_auto\u002Fv1756563746\u002Fimages\u002FPODD_valuation_model\u002FPODD_valuation_model.png?_i=AA 1400w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_396,c_scale\u002Ff_webp,q_auto\u002Fv1756563746\u002Fimages\u002FPODD_valuation_model\u002FPODD_valuation_model.png?_i=AA 300w\" sizes=\"auto, (max-width: 1939px) 100vw, 1939px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Insulet 公司指导估值模型\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">(TIKR\u003C\u002Fa>\u003C\u002Fstrong>)\u003C\u002Ffigcaption>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\u003Cp>Insulet 是 Omnipod 胰岛素给药系统的制造商，它代表了过去十年中最引人注目的医疗技术成长故事之一。与传统的管式胰岛素泵不同，Omnipod 基于贴片的设计提供了更简单、更隐蔽、更友好的用户体验，推动了 1 型和 2 型糖尿病患者的快速采用。这一创新帮助 Insulet 实现了每年 15-20% 以上的收入增长，并得到了美国强大的市场渗透率和不断增长的国际业务的支持。\u003C\u002Fp>\n\n\n\n\u003Cp>Insulet 持续增长的一个关键因素是其支付方覆盖范围不断扩大，这降低了采用门槛，扩大了客户群。最近推出的 Omnipod 5（首款通过 FDA 认证的无管胰岛素自动给药系统）等产品加深了 Insulet 的竞争护城河，使其始终处于糖尿病技术创新的前沿。随着全球糖尿病发病率的不断上升，Insulet 将产品差异化、强大的耗材经常性收入和国际扩张结合在一起，确保其稳居 10% 以上的增长类别。\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">使用 TIKR 的新估值模型在 30 秒内对任何股票进行估值（免费） >>>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-华尔街分析师看好这-5-家被低估的复合型企业-它们具有战胜市场的潜力\">\u003Cstrong>华尔街分析师看好这 5 家被低估的复合型企业，它们具有战胜市场的潜力\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>TIKR 刚刚发布了一份新的免费报告，介绍了 5 家复合型企业，这些企业的\u003Cstrong>价值\u003C\u002Fstrong>似乎\u003Cstrong>被低估了\u003C\u002Fstrong>，它们在过去曾\u003Cstrong>战胜过市场 \u003C\u002Fstrong>，而且根据分析师的估计，它们在 1-5 年的时间里可能会继续\u003Cstrong>跑\u003C\u002Fstrong> \u003Cstrong>赢大盘 \u003C\u002Fstrong>。\u003C\u002Fp>\n\n\n\n\u003Cp>在这里，您将了解到 5 家优质企业的详细情况，它们是：\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>强劲的收入增长和持久的竞争优势\u003C\u002Fli>\n\n\n\n\u003Cli>基于远期收益和预期收益增长的估值极具吸引力\u003C\u002Fli>\n\n\n\n\u003Cli>分析师预测和 TIKR 估值模型支持的长期上升潜力\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>这类股票可以带来巨大的长期回报，尤其是如果你能在它们还在折价交易时抓住它们。\u003C\u002Fp>\n\n\n\n\u003Cp>无论您是长期投资者，还是只想寻找以低于公允价值交易的优秀企业，本报告都将帮助您锁定高溢价机会。\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog-compoundersreport\">单击此处注册 TIKR，免费获得我们关于 5 家被低估的复合型企业的完整报告。\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-寻找新机遇\">\u003Cstrong>寻找新机遇？\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>看看\u003Cstrong> \u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">亿万富翁投资者都在买\u003C\u002Fa> \u003C\u002Fstrong>什么股票，\u003Cstrong> 这样 \u003C\u002Fstrong>你就能跟着聪明人赚钱了。\u003C\u002Fli>\n\n\n\n\u003Cli>利用 TIKR 的一体化易用平台，\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">在短短 5 分钟内分析股票\u003C\u002Fa>\u003C\u002Fstrong>。\u003C\u002Fli>\n\n\n\n\u003Cli>您推翻的岩石越多……您发现的机会就越多。\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">使用 TIKR 搜索 10 万多种全球股票、全球顶级投资者持有的股票等。\u003C\u002Fa>\u003C\u002Fstrong>\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-免责声明\">\u003Cstrong>免责声明\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>\u003Cem>请注意，TIKR 上的文章无意作为 TIKR 或我们内容团队的投资或财务建议，也不是买卖任何股票的建议。我们的内容基于 TIKR 终端的投资数据和分析师的估计。我们的分析可能不包括最近的公司新闻或重要更新。 \u003C\u002Fem>\u003Cem>TIKR 不持有所提及的任何股票。\u003C\u002Fem>\u003Cem> 感谢您的阅读，祝您投资愉快！\u003C\u002Fem>\u003C\u002Fp>\n",211,"zh","\u002Fblog\u002Fhealthcare-stocks-with-consistent-10-revenue-growth","healthcare-stocks-with-consistent-10-revenue-growth","images\u002FNEW-FEATURED-IMAGE-MAKER-12-1_688518da6d\u002FNEW-FEATURED-IMAGE-MAKER-12-1_688518da6d","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1760017218\u002Fimages\u002FNEW-FEATURED-IMAGE-MAKER-12-1_688518da6d\u002FNEW-FEATURED-IMAGE-MAKER-12-1_688518da6d.?_i=AA",{"altText":225,"imageCredit":237},"Canva",{"name":239,"slug":240,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":243},"Cate Ciplak","catetikr","author","",[],{"name":245,"slug":246,"role":247,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":248},"Thomas Richmond","thomastikr","editor",[],[250],{"name":251,"slug":252,"uri":253,"description":242,"postsCount":254},"股票评论","%e8%82%a1%e7%a5%a8%e8%af%84%e8%ae%ba","\u002Fblog\u002Fcategory\u002F%e8%82%a1%e7%a5%a8%e8%af%84%e8%ae%ba",0,[],{"title":225,"metaDesc":257,"opengraphDescription":257,"twitterTitle":225,"twitterDescription":257},"在保险公司的支持和全球需求的推动下，以下 10 只医疗保健类股票的收入增长率始终保持在 10%以上，是注重增长的投资者的首选。",{"title":225,"description":257,"twitterTitle":225,"twitterDescription":257,"author":239,"articlePublisher":259,"articlePublishedTime":226,"articleModifiedTime":227,"twitterLabel1":260,"twitterData1":261,"ogTitle":225,"ogDescription":257,"ogUrl":232,"ogImage":235,"ogImageWidth":262,"ogImageHeight":263,"ogImageSecureUrl":235,"ogImageAlt":225,"twitterImage":235},"TIKR.com","预计阅读时间","2 minutes",1200,630,[],[]]